ATE466938T1 - Prostata-spezifisches gen pcgem1 und methoden zu dessen verwendung zur erkennung, behandlung und prävention von prostatakrebs - Google Patents

Prostata-spezifisches gen pcgem1 und methoden zu dessen verwendung zur erkennung, behandlung und prävention von prostatakrebs

Info

Publication number
ATE466938T1
ATE466938T1 AT00918373T AT00918373T ATE466938T1 AT E466938 T1 ATE466938 T1 AT E466938T1 AT 00918373 T AT00918373 T AT 00918373T AT 00918373 T AT00918373 T AT 00918373T AT E466938 T1 ATE466938 T1 AT E466938T1
Authority
AT
Austria
Prior art keywords
prostate
prostate cancer
pcgem1
prevention
detection
Prior art date
Application number
AT00918373T
Other languages
English (en)
Inventor
Vasantha Srikantan
Zhiqiang Zou
Judd W Moul
Shiv Srivastava
Original Assignee
Jackson H M Found Military Med
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jackson H M Found Military Med filed Critical Jackson H M Found Military Med
Application granted granted Critical
Publication of ATE466938T1 publication Critical patent/ATE466938T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4748—Tumour specific antigens; Tumour rejection antigen precursors [TRAP], e.g. MAGE
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
AT00918373T 1999-03-26 2000-03-24 Prostata-spezifisches gen pcgem1 und methoden zu dessen verwendung zur erkennung, behandlung und prävention von prostatakrebs ATE466938T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US12646999P 1999-03-26 1999-03-26
PCT/US2000/007906 WO2000058470A1 (en) 1999-03-26 2000-03-24 Prostate-specific gene, pcgem1, and methods of using pcgem1 to detect, treat, and prevent prostate cancer

Publications (1)

Publication Number Publication Date
ATE466938T1 true ATE466938T1 (de) 2010-05-15

Family

ID=22425000

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00918373T ATE466938T1 (de) 1999-03-26 2000-03-24 Prostata-spezifisches gen pcgem1 und methoden zu dessen verwendung zur erkennung, behandlung und prävention von prostatakrebs

Country Status (7)

Country Link
EP (1) EP1185639B1 (de)
JP (1) JP4942248B2 (de)
AT (1) ATE466938T1 (de)
AU (1) AU778088B2 (de)
CA (1) CA2368385C (de)
DE (1) DE60044350D1 (de)
WO (1) WO2000058470A1 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2286304C (en) 1997-04-10 2007-08-07 Diagnocure Inc. Pca3, pca3 genes, and methods of use
US6828429B1 (en) 1999-03-26 2004-12-07 Henry M. Jackson Foundation For The Advancement Of Military Medicine Prostate-specific gene, PCGEM1, and the methods of using PCGEM1 to detect, treat, and prevent prostate cancer
JP2003510075A (ja) 1999-09-29 2003-03-18 ディグノキュアー・インコーポレーテッド 良性および悪性の前立腺組織におけるｐｃａ３メッセンジャーｒｎａ種
WO2002042776A2 (en) * 2000-11-01 2002-05-30 Diadexus, Inc. Compositions and methods relating to prostate specific genes and proteins
AU2002235164A1 (en) * 2000-11-06 2002-05-21 Diadexus, Inc. Compositions and methods relating to prostate specific genes and proteins
WO2002039431A2 (en) * 2000-11-06 2002-05-16 Diadexus, Inc. Compositions and methods relating to prostate specific genes and proteins
AU2002217991A1 (en) * 2000-11-21 2002-06-03 Diadexus, Inc. Compositions and methods relating to prostate specific genes and proteins
US20020150924A1 (en) * 2000-11-21 2002-10-17 Susana Salceda Compositions and methods relating to prostate specific genes and proteins
WO2002044332A2 (en) * 2000-12-01 2002-06-06 Origene Technologies Inc Prostate polynucleotides and uses
GB0119852D0 (en) * 2001-08-15 2001-10-10 Univ York Baculovirus
US7816087B2 (en) 2001-11-14 2010-10-19 The United States Of America As Represented By The Department Of Health And Human Services Gene expressed in prostate cancer and methods of use
JP2005538697A (ja) * 2002-04-19 2005-12-22 シエーリング アクチエンゲゼルシャフト 新規前立腺腫瘍特異的プロモーター
WO2004070056A2 (en) 2003-02-07 2004-08-19 Diagnocure Inc. Method to detect prostate cancer in a sample
CA2491067A1 (en) 2004-12-24 2006-06-24 Stichting Katholieke Universiteit Mrna rations in urinary sediments and/or urine as a prognostic marker for prostate cancer

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2055907T3 (es) 1989-03-07 1994-09-01 Genentech Inc Conjugados covalentes de lipidos y oligonucleotidos.
CA2071483C (en) 1989-10-24 2001-04-17 Mark Matteucci Oligonucleotide analogs with novel linkages
US5830686A (en) * 1994-01-13 1998-11-03 Calydon Tissue-specific enhancer active in prostate
JP2002510974A (ja) * 1997-06-27 2002-04-09 ヒューマン ジノーム サイエンシーズ，インコーポレイテッド ヒトｎｋ−３関連前立腺特異的遺伝子−１

Also Published As

Publication number Publication date
CA2368385A1 (en) 2000-10-05
EP1185639B1 (de) 2010-05-05
JP2003521236A (ja) 2003-07-15
AU778088B2 (en) 2004-11-18
JP4942248B2 (ja) 2012-05-30
DE60044350D1 (de) 2010-06-17
EP1185639A1 (de) 2002-03-13
CA2368385C (en) 2012-05-15
WO2000058470A1 (en) 2000-10-05
AU3919600A (en) 2000-10-16

Similar Documents

Publication Publication Date Title
ATE466938T1 (de) Prostata-spezifisches gen pcgem1 und methoden zu dessen verwendung zur erkennung, behandlung und prävention von prostatakrebs
WO2003009814A3 (en) Novel genes, compositions, kits, and methods for identification, assessment, prevention, and therapy of prostate cancer
WO2003004989A3 (en) Compositions, kits, and methods for identification, assessment, prevention, and therapy of breast cancer
TW200728465A (en) Compositions and methods for the therapy and diagnosis of prostate cancer
DE60126592D1 (de) Verfahren, zusammensetzungen und kits zur identifizierung und überwachung von brustkrebs
WO2002101075A9 (en) Novel genes, compositions, kits, and methods for identification, assessment, prevention, and therapy of cervical cancer
WO2001072962A3 (en) Novel prostate-specific or testis-specific nucleic acid molecules, polypeptides, and diagnostic and therapeutic methods
WO2004000094A8 (en) Predictive markers in cancer therapy
WO2001042467A3 (en) Genes, compositions, kits, and methods for identification, assessment, prevention, and therapy of cervical cancer
WO2004106495A3 (en) Compositions, kits, and methods for identification, assessment, prevention, and therapy of breast cancer
EP1151140A4 (de) Prostata-spezifische gene zur diagnose, prognose und behandlung von prostata-krebs
ATE488529T1 (de) Zusammensetzungen und verfahren zur behandlung von tumoren
MX9801264A (es) Control de la expresion del gen de cd44 para uso terapeutico.
AU2003293141A1 (en) Methods for identifying risk of breast cancer and treatments thereof
WO2004005530A3 (en) Compositions and methods for treatment and detection of multiple cancers
WO2003030725A3 (en) Pancreatic cancer diagnosis and therapies
ATE287722T1 (de) Mittel zur behandlung maligner erkrankungen unter verwendung des proteins yb-1
WO2003106648A3 (en) COMPOSITIONS AND METHODS RELATED TO BREAST SPECIFIC GENES AND PROTEINS
DE60039453D1 (de) Pin1 als stadiumsmarker der aggressivität und/oder der metastasierung abnormale zellwachstum
WO2002042463A3 (en) Compositions and methods relating to prostate specific genes and proteins
DK0950062T3 (da) Proteinmarkörer for esophageal cancer
WO2002042776A3 (en) Compositions and methods relating to prostate specific genes and proteins
WO2002039431A3 (en) Compositions and methods relating to prostate specific genes and proteins
BR0012301A (pt) Inibidores de crescimento de células epiteliais
WO2004048548A3 (en) Methods for identifying risk of breast cancer and treatments thereof

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties